These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 15808504)

  • 21. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.
    Su HL; Li SS
    Gene; 2002 Aug; 296(1-2):65-73. PubMed ID: 12383504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers.
    Rosas-Acosta G; Russell WK; Deyrieux A; Russell DH; Wilson VG
    Mol Cell Proteomics; 2005 Jan; 4(1):56-72. PubMed ID: 15576338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein.
    Takahashi H; Hatakeyama S; Saitoh H; Nakayama KI
    J Biol Chem; 2005 Feb; 280(7):5611-21. PubMed ID: 15569683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-Scale Purification of Small Ubiquitin-Like Modifier (SUMO)-Modified Proteins from
    Nie M; Boddy MN
    Cold Spring Harb Protoc; 2017 Mar; 2017(3):pdb.prot091603. PubMed ID: 28250213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme.
    Schwarz SE; Matuschewski K; Liakopoulos D; Scheffner M; Jentsch S
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):560-4. PubMed ID: 9435231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUMO-specific proteases and isopeptidases of the SENP family at a glance.
    Kunz K; Piller T; Müller S
    J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29559551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
    Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
    Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation--a new target for therapeutic intervention?
    Yang W; Sheng H; Homi HM; Warner DS; Paschen W
    J Neurochem; 2008 Aug; 106(3):989-99. PubMed ID: 18410505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SUMO-2/3 regulates topoisomerase II in mitosis.
    Azuma Y; Arnaoutov A; Dasso M
    J Cell Biol; 2003 Nov; 163(3):477-87. PubMed ID: 14597774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.
    Minty A; Dumont X; Kaghad M; Caput D
    J Biol Chem; 2000 Nov; 275(46):36316-23. PubMed ID: 10961991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation.
    Stelter P; Ulrich HD
    Nature; 2003 Sep; 425(6954):188-91. PubMed ID: 12968183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of SUMO substrates to a Cdc48-Ufd1-Npl4 segregase and STUbL pathway in fission yeast.
    Køhler JB; Tammsalu T; Jørgensen MM; Steen N; Hay RT; Thon G
    Nat Commun; 2015 Nov; 6():8827. PubMed ID: 26537787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SUMO modification modulates the transrepression activity of PLZF.
    Chao TT; Chang CC; Shih HM
    Biochem Biophys Res Commun; 2007 Jun; 358(2):475-82. PubMed ID: 17498654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin/26 S proteasome pathway.
    Hirano Y; Murata S; Tanaka K; Shimizu M; Sato R
    J Biol Chem; 2003 May; 278(19):16809-19. PubMed ID: 12615929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of SUMO-1 modified IκBα and complex formation with NF-κB.
    Lens Z; Dewitte F; Van Lint C; de Launoit Y; Villeret V; Verger A
    Protein Expr Purif; 2011 Dec; 80(2):211-6. PubMed ID: 21708266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
    Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
    Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
    Desterro JM; Rodriguez MS; Kemp GD; Hay RT
    J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
    Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
    Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.